It’s a short leisurely walk to the Institute of Psychiatry, a world leader in research into the treatment of mental illness. It’s here that we get the chance to hear about the drug Largactyl in a bit more depth. Fellow walkers are encouraged to share their knowledge and we are lucky enough have Peter Nicol, a former psychiatric nurse, in our midst. Nicol describes how the drug Largactyl was prescribed routinely. “When I first started working in psychiatric hospitals in the 1950s, we used to give Largactyl to patients, which produced the unfortunate side-effect of a shuffling walk,” he says.
Institute of Psychiatry
October 2, 2009 in Mental Health
More from Community Care
- ‘Our inspirational senior leaders invest in us’
- Podcast: Working together to be stronger for children and families
- Trusting instincts and the evidence: NQSWs reflect on the past year
- “The family safeguarding model gives families the platform to tell us who they are – not what they are”
- Podcast: How do you help children who cannot speak?
- How investment in social workers is paying off for practitioners and the children and families they support
- Peeling back the red tape and freeing up social workers
- Employer zone – showcasing a selection of the sector’s top recruiters